QNTM Labs Closes Series A Led by Intrinsic Capital Partners to Reinvent Pharmaceutical Lab Testing on a Global Scale

November 17, 2022 - Global News Wire

QNTM Labs has successfully closed its Series A funding round, spearheaded by Intrinsic Capital Partners. This funding is earmarked to transform pharmaceutical lab testing on a worldwide scale.